Scilex Holding Co

Scilex Holding Company (Nasdaq: SCLX) is a specialty pharmaceutical company that entered the public markets in December 2022 through a de-SPAC combination with Vickers Vantage Corp. I, a blank-check vehicle that completed its initial public offering in 2021 under the sponsorship of Vickers Financial Group Ltd. Focused on developing and commercializing non-opioid pain management therapies, Scilex operates within the specialty pharmaceuticals sector and has remained an active SEC filer since the merger close. The company submitted an 8-K current report on May 11, 2026, disclosing a material event to investors. For comprehensive filing history, deal analytics, and real-time data on SCLX, sign up for full access at SpacDesk.